Breast cancer: diagnostic and therapeutic options Emilio BombardieriLuca Gianni 17 April 2004 Pages: S1 - S2
Biomolecular features of clinical relevance in breast cancer Maria Grazia DaidoneAngelo ParadisoManfred Schmitt ReviewPaper 17 April 2004 Pages: S3 - S14
Circulating tumour markers in breast cancer Ettore SeregniAntonio ColiItalian Group RIA-IRMA Test, Italian Association of Nuclear Medicine (AIMN), Italy 04 May 2004 Pages: S15 - S22
Use of tomographic nuclear medicine procedures, SPECT and pinhole SPECT, with cationic lipophilic radiotracers for the evaluation of axillary lymph node status in breast cancer patients Giuseppe MadedduAngela Spanu 15 April 2004 Pages: S23 - S34
Breast scintigraphy today: indications and limitations Orazio SchillaciJohn R. Buscombe ReviewPaper 23 April 2004 Pages: S35 - S45
Sentinel node detection in pre-operative axillary staging Giuseppe TrifiròGiuseppe VialeGiovanni Paganelli 22 April 2004 Pages: S46 - S55
State of the art of current modalities for the diagnosis of breast lesions Cosimo Di Maggio ReviewPaper 15 April 2004 Pages: S56 - S69
FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions K. ScheidhauerC. WalterM. D. Seemann ReviewPaper 06 May 2004 Pages: S70 - S79
Biological characterisation of breast cancer by means of PET Andreas K. BuckHolger SchirrmeisterSven N. Reske ReviewPaper 04 May 2004 Pages: S80 - S87
99mTc-MIBI in the evaluation of breast cancer biology Silvana Del VecchioMarco Salvatore 23 April 2004 Pages: S88 - S96
FDG-PET for axillary lymph node staging in primary breast cancer Flavio CrippaAlberto GeraliEmilio Bombardieri 05 May 2004 Pages: S97 - S102
Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations Nanda C. KrakOtto S. HoekstraAdriaan A. Lammertsma ReviewPaper 22 April 2004 Pages: S103 - S111
FDG-PET in monitoring therapy of breast cancer H.-J. BiersackH. BenderH. Palmedo 27 April 2004 Pages: S112 - S117
FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer Wulf SiggelkowWerner RathMichael Zimny 14 May 2004 Pages: S118 - S124
Advantages and limitations of FDG PET in the follow-up of breast cancer Peter LindIsabel IgercKlaus Hausegger 15 April 2004 Pages: S125 - S134
PET/CT and breast cancer Barbara ZangheriCristina MessaFerruccio Fazio ReviewPaper 05 May 2004 Pages: S135 - S142
Current role of bone scan with phosphonates in the follow-up of breast cancer Lorenzo MaffioliLuigia FlorimonteIsabel Roca 16 April 2004 Pages: S143 - S148
The curability of breast cancer and the treatment of advanced disease Valentina GuarneriPier Franco Conte ReviewPaper 24 April 2004 Pages: S149 - S161
186Re-HEDP for metastatic bone pain in breast cancer patients Marnix G. E. H. LamJohn M. H. de KlerkPeter P. van Rijk 29 April 2004 Pages: S162 - S170
153Sm-EDTMP for bone pain palliation in skeletal metastases Carlo L. MainiSerenella BergomiRosa Sciuto ReviewPaper 04 May 2004 Pages: S171 - S178
The choice of the correct imaging modality in breast cancer management Emilio BombardieriLuca Gianni ReviewPaper 04 May 2004 Pages: S179 - S186
